206 related articles for article (PubMed ID: 9571193)
1. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes.
Ikeda M; Sugiyama K; Tanaka T; Tanaka K; Sekihara H; Shimotohno K; Kato N
Biochem Biophys Res Commun; 1998 Apr; 245(2):549-53. PubMed ID: 9571193
[TBL] [Abstract][Full Text] [Related]
2. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells.
Ikeda M; Nozaki A; Sugiyama K; Tanaka T; Naganuma A; Tanaka K; Sekihara H; Shimotohno K; Saito M; Kato N
Virus Res; 2000 Jan; 66(1):51-63. PubMed ID: 10653917
[TBL] [Abstract][Full Text] [Related]
3. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
Chien YJ; Chen WJ; Hsu WL; Chiou SS
Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
[TBL] [Abstract][Full Text] [Related]
4. Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes.
Hara K; Ikeda M; Saito S; Matsumoto S; Numata K; Kato N; Tanaka K; Sekihara H
Hepatol Res; 2002 Nov; 24(3):228. PubMed ID: 12393024
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
[TBL] [Abstract][Full Text] [Related]
6. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells.
Ammendolia MG; Marchetti M; Superti F
Antiviral Res; 2007 Dec; 76(3):252-62. PubMed ID: 17881064
[TBL] [Abstract][Full Text] [Related]
7. Glycosaminoglycans are not indispensable for the anti-herpes simplex virus type 2 activity of lactoferrin.
Marchetti M; Ammendolia MG; Superti F
Biochimie; 2009 Jan; 91(1):155-9. PubMed ID: 18534197
[TBL] [Abstract][Full Text] [Related]
8. Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytes.
Abe K; Nozaki A; Tamura K; Ikeda M; Naka K; Dansako H; Hoshino HO; Tanaka K; Kato N
Microbiol Immunol; 2007; 51(1):117-25. PubMed ID: 17237607
[TBL] [Abstract][Full Text] [Related]
9. Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes.
Redwan el-RM; Tabll A
J Immunoassay Immunochem; 2007; 28(3):267-77. PubMed ID: 17613672
[TBL] [Abstract][Full Text] [Related]
10. The anti-papillomavirus activity of human and bovine lactoferricin.
Mistry N; Drobni P; Näslund J; Sunkari VG; Jenssen H; Evander M
Antiviral Res; 2007 Sep; 75(3):258-65. PubMed ID: 17481742
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-alpha.
Ikeda M; Mori K; Ariumi Y; Dansako H; Kato N
FEBS Lett; 2009 May; 583(9):1434-8. PubMed ID: 19332062
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin inhibits human papillomavirus binding and uptake in vitro.
Drobni P; Näslund J; Evander M
Antiviral Res; 2004 Oct; 64(1):63-8. PubMed ID: 15451180
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin.
Li S; Zhou H; Huang G; Liu N
Med Microbiol Immunol; 2009 Feb; 198(1):19-25. PubMed ID: 18810491
[TBL] [Abstract][Full Text] [Related]
14. Bovine lactoferrin inhibits influenza A virus induced programmed cell death in vitro.
Pietrantoni A; Dofrelli E; Tinari A; Ammendolia MG; Puzelli S; Fabiani C; Donatelli I; Superti F
Biometals; 2010 Jun; 23(3):465-75. PubMed ID: 20232110
[TBL] [Abstract][Full Text] [Related]
15. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
[TBL] [Abstract][Full Text] [Related]
16. Bovine lactoferrin: involvement of metal saturation and carbohydrates in the inhibition of influenza virus infection.
Pietrantoni A; Ammendolia MG; Superti F
Biochem Cell Biol; 2012 Jun; 90(3):442-8. PubMed ID: 22332831
[TBL] [Abstract][Full Text] [Related]
17. Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system.
Ito T; Yasui K; Mukaigawa J; Katsume A; Kohara M; Mitamura K
Hepatology; 2001 Sep; 34(3):566-72. PubMed ID: 11526543
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment.
Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Bartolomé J; Carreño V
Clin Infect Dis; 2006 Nov; 43(10):1277-83. PubMed ID: 17051492
[TBL] [Abstract][Full Text] [Related]
19. A reliable internally controlled RT-nested PCR method for the detection of hepatitis C virus RNA.
Nozaki A; Naganuma A; Nakamura T; Tanaka K; Sekihara H; Kato N
Acta Med Okayama; 2000 Dec; 54(6):253-7. PubMed ID: 11132918
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans.
Marchetti M; Trybala E; Superti F; Johansson M; Bergström T
Virology; 2004 Jan; 318(1):405-13. PubMed ID: 14972565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
